Interpace Biosciences Files for $20M Uplisting Offering on Nasdaq
IDXGD is trading near its 52-week low of $5.973 (8.3% above the low).
Summary
Interpace Biosciences filed an S-1 to raise $20 million in a firm commitment offering, contingent on Nasdaq listing approval, following a 1-for-5 reverse stock split.
Updates
· SEC S-1/A — The offering is now 3.1M shares at an estimated $6.00-$7.00 per share, with net proceeds of about $17.9M ($20.8M if over-allotment exercised).
Key Events · Financing and Capital Events · IDXGD
-
$20M Firm Commitment Offering
Company registering $20M of common stock with Lake Street Capital Markets as sole bookrunner, plus a $3M over-allotment option.
-
Nasdaq Uplisting Contingency
Offering closing is contingent on receiving conditional approval to list on Nasdaq under symbol IDXG; currently quoted on OTCID.
-
Reverse Stock Split
1-for-5 reverse split effective August 27, 2026, to meet Nasdaq minimum bid price requirement.
-
Dilution to New Investors
At assumed $6.47 offering price, new investors face immediate dilution of $2.01 per share; net tangible book value rises to $4.46 per share.
Analysis · IDXGD · Industrial Applications And Services
Interpace Biosciences is registering a $20 million firm commitment underwritten offering, with an over-allotment option of up to $3 million. The offering is contingent on receiving conditional approval to list on Nasdaq, marking a potential transition from the OTCID to a major exchange. The company recently executed a 1-for-5 reverse stock split to meet Nasdaq's minimum bid price requirement. Net proceeds of approximately $17.8 million will fund working capital, capital expenditures, and development of new diagnostic tests. Existing shareholders face immediate dilution of $2.01 per share at the assumed $6.47 offering price.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 29% of the 1653 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.58%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IDXGD was trading at $6.47 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $35.8M. The 52-week trading range was $5.97 to $60.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.